|
Re: Breakthrough Therapy Designation Application
|
2
|
Resverlogix Corp.
|
Dec 06, 2019 11:39AM
|
|
Re: Breakthrough Therapy Designation Application
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 11:58AM
|
|
Re: Brilanta-AZ
|
7
|
Resverlogix Corp.
|
Apr 19, 2018 10:18AM
|
|
Re: Brilinta-AZ
|
8
|
Resverlogix Corp.
|
Apr 19, 2018 12:36PM
|
|
Re: Bringing us back on track
|
6
|
Resverlogix Corp.
|
Feb 29, 2020 09:59PM
|
|
Re: Broker Meeting 23 Feb
|
4
|
Resverlogix Corp.
|
Mar 01, 2017 12:31PM
|
|
Re: Broker Meeting 23 Feb
|
3
|
Zenith Epigenetics
|
Mar 01, 2017 12:37PM
|
|
Re: Broker Meeting 23 Feb
|
2
|
Resverlogix Corp.
|
Mar 01, 2017 12:58PM
|
|
Re: Broker Meeting 23 Feb
|
2
|
Resverlogix Corp.
|
Mar 01, 2017 02:01PM
|
|
Re: Bromodomain and extraterminal domain (BET) inhibitors in clinical development
|
3
|
Resverlogix Corp.
|
Apr 16, 2019 08:38PM
|
|
Re: Bromodomain and extraterminal domain (BET) inhibitors in clinical development
|
3
|
Resverlogix Corp.
|
Apr 16, 2019 09:42PM
|
|
Re: Bromodomain-2 Selective BET inhibitors
|
4
|
Resverlogix Corp.
|
Apr 22, 2018 07:47PM
|
|
Re: Bromoscan
|
2
|
Resverlogix Corp.
|
Apr 25, 2019 08:32AM
|
|
Re: BTI just filed a Other securityholders documents - English
|
3
|
BIOASIS TECHNOLOGIES INC
|
Oct 16, 2018 01:22PM
|
|
Re: BTI:TSXV; BIOAF:OTCQB: "Announces Rare Diseases Strategic Alliance With Chiesi"
|
3
|
BIOASIS TECHNOLOGIES INC
|
Jun 29, 2020 04:16PM
|
|
Re: BTI:TSXV; BIOAF:OTCQB: "Announces Rare Diseases Strategic Alliance With Chiesi"
|
4
|
BIOASIS TECHNOLOGIES INC
|
Jun 29, 2020 04:31PM
|
|
Re: Buy, sell or fold
|
2
|
Resverlogix Corp.
|
Dec 04, 2019 10:04PM
|
|
Re: Buy-Out
|
6
|
Resverlogix Corp.
|
Nov 20, 2019 09:50PM
|
|
Re: Buyout?......
|
3
|
Resverlogix Corp.
|
Jun 03, 2019 07:50AM
|
|
Re: Buyout?......
|
4
|
Resverlogix Corp.
|
Jun 02, 2019 10:07PM
|
